Ciproxin HC Ear Drops is a potent otic solution designed for the treatment of bacterial ear infections. This pharmaceutical product combines the broad-spectrum antibacterial action of Ciprofloxacin with the anti-inflammatory benefits of hydrocortisone to effectively manage symptoms and eradicate infection.
Product Specifications:
- Active ingredient: Ciprofloxacin hydrochloride 2mg/ml
- Secondary component: Hydrocortisone 10mg/ml
- Formulation: Sterile otic suspension
- Packaging: Dropper bottle for precise application
- Volume: Typically available in 10 ml bottles
- Storage: Store below 25°C (Do not freeze)
- Shelf life: Check packaging for expiration date
Common Applications:
- Treatment of otitis externa in patients with susceptible strains of bacteria
- Management of middle ear infections (otitis media) in patients with tympanostomy tubes
- Reduction of inflammation and pain associated with bacterial ear infections
User Groups:
- Individuals diagnosed with bacterial ear infections
- Patients with tympanostomy tubes experiencing otitis media
- Suitable for adults and children over the age of 2 years
Supplier Overview - Novartis:
Novartis is a global healthcare company that stands at the forefront of pharmaceutical development and production. With a strong commitment to research and innovation, Novartis has established itself as an authority in various therapeutic areas, including anti-infectives. Their dedication to quality, safety, and efficacy is reflected in their comprehensive portfolio of medications, which includes Ciproxin HC Ear Drops. Novartis's expertise in the field of otic infections ensures that Ciproxin HC Ear Drops is a product that healthcare professionals and patients can trust for effective treatment outcomes.